These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats. Robertson GS; Fine A; Robertson HA Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908 [TBL] [Abstract][Full Text] [Related]
4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
5. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. Nikkhah G; Bentlage C; Cunningham MG; Björklund A J Neurosci; 1994 Jun; 14(6):3449-61. PubMed ID: 7911516 [TBL] [Abstract][Full Text] [Related]
6. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat. Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295 [TBL] [Abstract][Full Text] [Related]
7. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Hu XT; Brooderson RJ; White FJ Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592 [TBL] [Abstract][Full Text] [Related]
8. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa. Blunt SB; Jenner P; Marsden CD Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107 [TBL] [Abstract][Full Text] [Related]
9. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
10. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa. Blunt SB; Jenner P; Marsden CD Brain Res; 1992 Jun; 582(2):299-311. PubMed ID: 1393551 [TBL] [Abstract][Full Text] [Related]
11. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Paul ML; Currie RW; Robertson HA Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877 [TBL] [Abstract][Full Text] [Related]
12. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions. Boldry RC; Chase TN; Engber TM J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390 [TBL] [Abstract][Full Text] [Related]
13. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. Olsson M; Nikkhah G; Bentlage C; Björklund A J Neurosci; 1995 May; 15(5 Pt 2):3863-75. PubMed ID: 7751951 [TBL] [Abstract][Full Text] [Related]
14. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants. Rioux L; Gaudin DP; Gagnon C; Di Paolo T; Bédard PJ Neuroscience; 1991; 44(1):75-83. PubMed ID: 1770999 [TBL] [Abstract][Full Text] [Related]
15. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. Zhang SP; Zhou LW; Weiss B J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459 [TBL] [Abstract][Full Text] [Related]
16. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
18. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Delfs JM; Kelley AE Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467 [TBL] [Abstract][Full Text] [Related]
19. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts. Blunt S; Jenner P; Marsden CD Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916 [TBL] [Abstract][Full Text] [Related]
20. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]